Kaohsiung, Taiwan

Kim-Hong Gan

This inventor holds 1 USPTO granted patent. Top assignee: Kaohsiung Medical University. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kim-Hong Gan. Retrieved from https://idiyas.com/inventor/kim-hong-gan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kim-Hong Gan: Innovator in Pharmaceutical Compositions

Introduction

Kim-Hong Gan is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on ursolic acid derivatives. His research focuses on developing compositions that exhibit anticancer and anti-inflammatory effects.

Latest Patents

Kim-Hong Gan holds 1 patent for his invention titled "Ursolic acid derivative and pharmaceutical composition thereof." This patent encompasses several ursolic acid derivatives and their pharmaceutical compositions, which are designed to provide at least one of an anticancer and an anti-inflammatory effect. Additionally, he has developed a method for increasing reactive oxygen species in a cell, which involves administering a pharmaceutical composition that includes an ursolic acid derivative.

Career Highlights

Gan is affiliated with Kaohsiung Medical University, where he continues to advance his research in pharmaceutical sciences. His work has the potential to impact the treatment of various diseases, particularly those related to cancer and inflammation.

Collaborations

Some of his notable coworkers include Chun-Nan Lin and Huang-Yao Tu, who have collaborated with him on various research projects.

Conclusion

Kim-Hong Gan's innovative work in the development of ursolic acid derivatives showcases his commitment to advancing pharmaceutical science. His contributions may lead to significant advancements in medical treatments for cancer and inflammation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…